ALB and pneumocystosis: The use of four or more clinical manifestations (cough, dyspnea, fever, chest pain, and weight loss) for NH-PCP patients and albumin ≤30 g/L for HIV-PCP patients as predictors could allow early recognition of the risk of PCP and avoid further deterioration in the patient's condition.